Literature DB >> 26416394

Levetiracetam for the treatment of status epilepticus.

Fangshuo Zheng1, Chao Du1, Xuefeng Wang.   

Abstract

Status epilepticus (SE) is a common, severe neurological disorder, and prolonged seizures in SE may result in irreversible brain damage in association with high disability and mortality rates. Thus, termination of seizures as soon as possible is vital for the successful treatment of this disease. Levetiracetam, a new broad-spectrum anti-epileptic drug, can be used to rapidly and effectively control SE episodes with few side effects. Thus, an understanding of the use of this drug to treat SE will help clinicians to more effectively control SE and improve patient prognosis.

Entities:  

Keywords:  epilepsy; levetiracetam; prognosis; seizure; status epilepticus

Mesh:

Substances:

Year:  2015        PMID: 26416394     DOI: 10.1586/14737175.2015.1088785

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  3 in total

1.  Polytherapy as first-line in status epilepticus: should we change our practice? "Time is brain"!

Authors:  Ashalatha Radhakrishnan
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Antiepileptic Drug Therapy for Status Epilepticus.

Authors:  Daeyoung Kim; Jae Moon Kim; Yong Won Cho; Kwang Ik Yang; Dong Wook Kim; Soon Tae Lee; Young Joo No; Jong Geun Seo; Jung Ick Byun; Kyung Wook Kang; Keun Tae Kim
Journal:  J Clin Neurol       Date:  2021-01       Impact factor: 3.077

Review 3.  Treatment of Established Status Epilepticus.

Authors:  Jessica J Falco-Walter; Thomas Bleck
Journal:  J Clin Med       Date:  2016-04-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.